Literature DB >> 28269751

Synergistic efficacy of Cullin1 and MMP-2 expressions in diagnosis and prognosis of colorectal cancer.

Jianliang Deng1,1, Wenjiao Chen1,1, Yuan Du2,1, Weiming Wang1, Guoqiang Zhang1, Yuehua Tang1, Zhangjun Qian1, Ping Xu1, Zhihong Cao3, Yan Zhou1.   

Abstract

BACKGROUND: Cullin1 and MMP-2 have been identified as important markers in various cancers, but their roles in colorectal cancer (CRC) have remained to be discovered. The aim of this study was to investigate the expression pattern and significance of Cullin1 and MMP-2 in CRC.
METHODS: A total of 470 CRC patients were enrolled. Archival paraffin-embedded CRC tissue samples were used to generate tissue microarray blocks, which were immunohistochemically stained for Cullin1 and MMP-2. Prognostic and predictive role of Cullin1 and MMP-2 expression was evaluated by univariate and multivariate analysis, respectively. Values of p < 0.05 were considered statistically significant.
RESULTS: Cullin1 and MMP-2 protein levels were significantly upregulated in CRC tissues compared with adjacent noncancerous tissues. High tumoral Cullin1 or MMP-2 expression significantly correlated with shorter overall survival (OS), as well as with clinicopathologic characteristics in patients. Multivariate regression analysis showed that high Cullin1 and MMP-2 expressions, separately and together, were independent negative markers of OS.
CONCLUSION: Cullin1 and MMP-2 expressions could be novel diagnostic and prognostic markers for CRC patients.

Entities:  

Keywords:  Cullin1; MMP-2; colorectal cancer; diagnosis; prognosis

Mesh:

Substances:

Year:  2017        PMID: 28269751     DOI: 10.3233/CBM-160341

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  5 in total

1.  DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.

Authors:  Weimin Wang; Haibo Wang; Liangliang Xiang; Tengyang Ni; Feng Jin; Jianliang Deng; Yunlei Zhang; Ishikawa Shintaro; Yan Zhou; Yanqing Liu
Journal:  Oncol Rep       Date:  2020-04-23       Impact factor: 3.906

Review 2.  Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).

Authors:  Loganathan Rangasamy; Bruno Di Geronimo; Irene Ortín; Claire Coderch; José María Zapico; Ana Ramos; Beatriz de Pascual-Teresa
Journal:  Molecules       Date:  2019-08-16       Impact factor: 4.411

3.  CUL1-Mediated Organelle Fission Pathway Inhibits the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Ran Li; Feng Xu; Xiao Wu; Shaoping Ji; Ruixue Xia
Journal:  Comput Math Methods Med       Date:  2020-05-26       Impact factor: 2.238

4.  ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.

Authors:  Aline Simoneti Fonseca; Anelisa Ramão; Matheus Carvalho Bürger; Jorge Estefano Santana de Souza; Dalila Lucíola Zanette; Greice Andreotti de Molfetta; Luiza Ferreira de Araújo; Rafaela de Barros E Lima Bueno; Graziela Moura Aguiar; Jessica Rodrigues Plaça; Cleidson de Pádua Alves; Anemari Ramos Dinarte Dos Santos; Daniel Onofre Vidal; Gyl Eanes Barros Silva; Rodrigo Alexandre Panepucci; Fernanda Maris Peria; Omar Feres; José Joaquim Ribeiro da Rocha; Marco Antonio Zago; Wilson Araújo Silva
Journal:  BMC Cancer       Date:  2021-03-01       Impact factor: 4.430

Review 5.  Combined Radiochemotherapy: Metalloproteinases Revisited.

Authors:  Verena Waller; Martin Pruschy
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.